Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Utah
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Emory University
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine